| Pharmaceutical Information |
| Drug Name |
Acebutolol hydrochloride |
| Drug ID |
BADD_D00020 |
| Description |
A cardioselective beta-adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm as well as weak inherent sympathomimetic action. |
| Indications and Usage |
For the management of hypertension and ventricular premature beats in adults. |
| Marketing Status |
approved; investigational |
| ATC Code |
C07AB04 |
| DrugBank ID |
DB01193
|
| KEGG ID |
D00597
|
| MeSH ID |
D000070
|
| PubChem ID |
441307
|
| TTD Drug ID |
D0HD9K
|
| NDC Product Code |
52932-0719; 65162-670; 58159-081; 65162-669; 62559-255; 51407-666; 42291-010; 62559-256; 50268-050; 53746-669; 51927-2906; 68069-0009; 53746-670; 51407-667 |
| UNII |
B025Y34C54
|
| Synonyms |
Acebutolol | Acetobutolol | Acebutolol Hydrochloride | M&B-17803 A | M&B 17803 A | M&B17803 A | M & B 17803A | Neptal | Prent | Rhotral | Sectral | Monitan | Apo-Acebutolol | Apo Acebutolol | ApoAcebutolol | Novo-Acebutolol | Novo Acebutolol | NovoAcebutolol |
|
| Chemical Information |
| Molecular Formula |
C18H29ClN2O4 |
| CAS Registry Number |
34381-68-5 |
| SMILES |
CCCC(=O)NC1=CC(=C(C=C1)OCC(CNC(C)C)O)C(=O)C.Cl |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
